Product NDC: | 57664-176 |
Proprietary Name: | HYDROCODONE BITARTRATE AND ACETAMINOPHEN |
Non Proprietary Name: | HYDROCODONE BITARTRATE AND ACETAMINOPHEN |
Active Ingredient(s): | 325; 10 mg/1; mg/1 & nbsp; HYDROCODONE BITARTRATE AND ACETAMINOPHEN |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 57664-176 |
Labeler Name: | Caraco Pharmaceutical Laboratories Ltd |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090118 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090330 |
Package NDC: | 57664-176-83 |
Package Description: | 30 TABLET in 1 BOTTLE (57664-176-83) |
NDC Code | 57664-176-83 |
Proprietary Name | HYDROCODONE BITARTRATE AND ACETAMINOPHEN |
Package Description | 30 TABLET in 1 BOTTLE (57664-176-83) |
Product NDC | 57664-176 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | HYDROCODONE BITARTRATE AND ACETAMINOPHEN |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20090330 |
Marketing Category Name | ANDA |
Labeler Name | Caraco Pharmaceutical Laboratories Ltd |
Substance Name | ACETAMINOPHEN; HYDROCODONE BITARTRATE |
Strength Number | 325; 10 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Opioid Agonist [EPC],Opioid Agonists [MoA] |